Chinook Therapeutics shares rise on promising results for kidney disease drugs from B.C. company

📆 2022-05-21 오전 8:33:00
📰 globeandmail

⏱ Reading Time:
31 sec. here
2 min. at publisher
📊 Quality Score:
News: 16%
Publisher: 92%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Chinook said early Thursday that eight subjects taking its BION-1301 antibody for IgA nephropathy had experienced a 48.8 per cent reduction in protein in their urine, or proteinuria – a key measure of the drug’s success – after six months

Shares in Chinook Therapeutics Inc. rose for a second straight day Friday after the Canadian-American drug developer reported promising preliminary results for two drugs it is developing to treat a rare kidney disease.

Chinook’s Nasdaq-traded stock rose 10 per cent on Thursday on the BION-1301 news and 8.4 per cent Friday after publication of the atrasentan data. It closed the week at US$15.01. Chinook is running a separate, advanced efficacy human trial for atrasentan involving 320 patients, with half of participants set to receive the drug and the balance taking a placebo. Results are expected in 2024. Mr. Dobmeier said this week’s results were from “more of a signal-seeking trial” adding that despite the lack of a control group, “it really does provide strong evidence that this drug is working well in IgAN patients.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

댓글 쓰기

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Government to release business case in support of new Royal B.C. MuseumProvincial government to reveal plans for new Royal B.C. Museum Cash grab for insiders and destroying BC history. Woke joke. Cost to BC taxpayers 77 million, museum about Colonialization, racism, and indigenous history, they pay zero, ZERO, ZERO, oh goody, thank you NDP, next time money laundering Liberals, just love politicians. It’s woke BS. Just like the phrase “unmarked graves.”
출처: globeandmail - 🏆 5. / 92 더 많은 것을 읽으십시오 »